Trial Profile
Association of dolutegravir plasma trough concentration with central nervous system side-effects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Mar 2017
Price :
$35
*
At a glance
- Drugs Dolutegravir (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions
- 16 Feb 2017 Results presented at the 24th Conference on Retroviruses and Opportunistic Infections
- 30 Dec 2016 New trial record